Central Nervous System Cancer
8
4
5
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
12.5%
1 terminated out of 8 trials
50.0%
-36.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (8)
Niraparib in Tumors Metastatic to the CNS
Integrated Cancer Repository for Cancer Research
Short Course Radiotherapy
Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System
CNS Qualitative Interview
Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention
Cyberknife Radiosurgery and Quality of Life